Main Menu

About us

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years.

The ICR is led by our Interim Chief Executive, Professor Paul Workman – an expert in cancer drug discovery. We lead the world at isolating cancer-related genes and discovering new targeted cancer drugs. Together with our hospital partner The Royal Marsden, we are rated in the top four centres for cancer research and treatment worldwide.

We are a college of the University of London, providing postgraduate higher education of international distinction. The ICR has charitable status and relies on support from partner organisations, charities, donors and the general public.

  • Our research

    At the ICR we are researching how to treat the differences between cancers – an approach known as personalised medicine.

    About our research
  • Our students

    The ICR is a college of the University of London, and educating and training the next generation of cancer researchers and clinicians is a core part of our mission.

    Study at the ICR
  • Our fundraising

    Our donors and supporters play a vital role in helping researchers at the ICR to make the discoveries that defeat cancer.

    Make a donation
1/

Our history of achievements

For more than 100 years, the ICR has been pioneering discoveries into cancer and its treatment.

Discover more

Annual Report

The Annual Report and Accounts provides the ICR's accounts for the end of each financial year.

Read our 2013 Annual Report

Policy and factsheets

The ICR has outlined its position on a number of policy issues in scientific and medical research.

Find out more
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.